by Standigm
ADMET prediction for drug discovery using quantum-informed AI models trained on experimental and in silico data.
Computational Drug Safety & PKPD Modeling
by Instem
In silico toxicity predictions with 100+ FDA-collaborated models for pharmaceutical safety, impurity assessment, and regulatory compliance.
Computational Drug Safety & PKPD Modelingby Instem
Weight of Evidence assessment for carcinogenicity risk using six integrated modules aligned with ICH S1B guidelines.
Computational Drug Safety & PKPD Modelingby Instem
In silico toxicology assessment leveraging computational models and 600,000+ studies for chemical safety evaluation.
Computational Drug Safety & PKPD Modelingby Instem
Early toxicology risk assessment and safety prediction for drug development using integrated preclinical and clinical data.
Computational Drug Safety & PKPD Modeling
by Certara
PK/PD analysis and modeling for non-compartmental analysis, population PK, IVIVC, and toxicokinetic studies.
Computational Drug Safety & PKPD Modelingby Certara
Quantitative systems pharmacology modeling with AI to integrate biological and pharmacological insights for drug efficacy and safety predictions.
Computational Drug Safety & PKPD Modelingby Certara
PBPK modeling and simulation for predicting drug behavior in diverse populations.
Computational Drug Safety & PKPD Modeling
by Simulations Plus
PBPK and biopharmaceutics modeling and simulation for predicting drug absorption, bioavailability, and pharmacokinetics across multiple dosage routes.
Computational Drug Safety & PKPD Modelingby Simulations Plus
Population PK/PD modeling, non-compartmental analysis, and simulation for pharmacometrics and model-informed drug development.
Computational Drug Safety & PKPD Modelingby Simulations Plus
AI/ML prediction of 175+ ADMET and pharmacokinetic properties, including metabolism, toxicity, and solubility, with integrated PBPK simulation and AI-driven drug design.
Computational Drug Safety & PKPD Modelingby Simulations Plus
Quantitative systems toxicology modeling for predicting drug-induced liver injury and mechanistic insight into DILI responses across species.
Computational Drug Safety & PKPD Modelingby Simulations Plus
Quantitative systems pharmacology modeling, SimPops® optimization, and clinical simulation for drug development and trial design.
Computational Drug Safety & PKPD Modelingby Simulations Plus
Computational modeling of metabolic dysfunction-associated steatotic liver disease to predict treatment efficacy for MASLD and MASH therapies.
Computational Drug Safety & PKPD Modelingby Simulations Plus
Mechanistic modeling to predict drug-induced kidney injury risk and understand renal safety mechanisms for safer drug design.
Computational Drug Safety & PKPD Modelingby Simulations Plus
Mechanistic QSP modeling for idiopathic pulmonary fibrosis drug development, efficacy prediction, and clinical trial optimization.
Computational Drug Safety & PKPD Modelingby Simulations Plus
Quantitative systems pharmacology modeling to predict weight loss efficacy and nausea side effects for obesity therapies.
Computational Drug Safety & PKPD Modeling
by TrialKey
AI-driven biostatistical validation and predictive modeling for optimizing clinical trial design and outcomes.
Computational Drug Safety & PKPD Modeling
by Clarivate Plc
Integrated preclinical and clinical safety data intelligence for anticipating drug toxicity risks and competitive advantage.
Computational Drug Safety & PKPD Modeling
by Medidata
Regulatory-grade patient-level data, AI-driven modeling, and synthetic control arms for safer protocols and more efficient clinical development.
Computational Drug Safety & PKPD Modeling